| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 01/17/2002 | WO2001030362A3 Ribozyme therapy for the treatment of proliferative skin and eye diseases |
| 01/17/2002 | WO2001027290A3 Aortic carboxypeptidase-like protein and nucleic acids encoding same |
| 01/17/2002 | WO2001022972A3 Immunostimulatory nucleic acids |
| 01/17/2002 | WO2001021656A3 Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors |
| 01/17/2002 | WO2001016377A3 Diagnostics and therapeutics for osteoporosis |
| 01/17/2002 | WO2001016293A3 Dna encoding the human serine protease t |
| 01/17/2002 | WO2001013117A3 Proteins, genes and their use for diagnosis and treatment of breast cancer |
| 01/17/2002 | WO2001012598A3 METHODS OF INHIBITING BINDING OF β-SHEET FIBRIL TO RAGE AND CONSEQUENCES THEREOF |
| 01/17/2002 | WO2001010468A3 Drug-carrier complexes and methods of use thereof |
| 01/17/2002 | WO2000078971A3 Atp binding cassette transporter protein abc1 popypeptides |
| 01/17/2002 | WO2000078953A3 Human transport proteins |
| 01/17/2002 | WO2000078952A3 Human rna metabolism proteins (rmep) |
| 01/17/2002 | WO2000077192A9 Reg-binding protein |
| 01/17/2002 | WO2000060077A3 Compounds for therapy and diagnosis of lung cancer and methods for their use |
| 01/17/2002 | WO2000025798A8 Treatment of parkinson's disease with oligonucleotides |
| 01/17/2002 | US20020007073 Capable of producing complexes with polynucleotides (DNA, RNA, antisense oligonucleotides, ribozymes); suitable as vectors for transfection |
| 01/17/2002 | US20020006914 Enhancing the sensitivity of tumor cells to therapies |
| 01/17/2002 | US20020006912 Suppression of nuclear factor-kappab dependent processes using oligonucleotides |
| 01/17/2002 | US20020006663 p27 and p21 in gene therapies |
| 01/17/2002 | US20020006661 Controlling gene expression in living cells |
| 01/17/2002 | US20020006640 Uteroglobin-like polynucleotides, polypeptides, and antibodies |
| 01/17/2002 | US20020006639 Nucleotide sequences coding asthma associated protein; for use in the diagnosis and treatment of genetic disorders associated with inflammation and air passage blockage |
| 01/17/2002 | US20020006637 Particle-mediated transformation of animal tissue cells |
| 01/17/2002 | US20020006413 Stimulating an immune response in a patient having an adenocarcinoma, comprising administering to such patient one or more allogenic tumor cells selected from SW620 cell, COLO 205 cell, and SW403 cell |
| 01/17/2002 | US20020006410 Method for treating inflammatory diseases using heat shock proteins |
| 01/17/2002 | US20020006398 Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions |
| 01/17/2002 | US20020006397 Delivering a cytotoxic agent which is one or more of herpes simplex virus thymidine kinase (HSV-tk), gancicolvir, or a rejection antigen, into a antigenic biniding protein APBP molecule to induce lysis of target cell |
| 01/17/2002 | US20020006396 Method of treating portal hypertension |
| 01/17/2002 | US20020006395 Defective adenoviruses including a therapeutic gene and an immunoprotective gene |
| 01/17/2002 | CA2427066A1 Method for the recovery and application of human defensins as biologically active proteins for the treatment of infections and other diseases |
| 01/17/2002 | CA2415544A1 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/17/2002 | CA2415483A1 Antisense compositions targeted to .beta.1 adrenoceptor-specific mrna and methods of use |
| 01/17/2002 | CA2415422A1 Chromosome 3p21.3 genes are tumor suppressors |
| 01/17/2002 | CA2415127A1 Down syndrome critical region 1-like 1 proteins |
| 01/17/2002 | CA2414926A1 Microspheres and adjuvants for dna vaccine delivery |
| 01/17/2002 | CA2414374A1 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 01/17/2002 | CA2414272A1 Bifunctional molecules and vectors complexed therewith for targeted gene delivery |
| 01/17/2002 | CA2412764A1 Stimulation of cellular regeneration and differentiation in the inner ear |
| 01/16/2002 | EP1172654A1 Diagnostic method based on the detection of the L1 adhesion molecule for ovarian and endometrial tumors |
| 01/16/2002 | EP1172375A1 Gene expression, genome alteration and reporter gene expression in myofibroblasts and myofibroblasts-like cells by using the regulatory regions within the alpha smooth muscle alpha-actin gene |
| 01/16/2002 | EP1171626A1 50 human secreted proteins |
| 01/16/2002 | EP1171622A1 Cassette regulating the expression of a heterologous nucleic acid in a eucaryotic cell, especially a muscle cell |
| 01/16/2002 | EP1171616A1 Method for enhancing myoblast migration and invasion in the context of gene therapy |
| 01/16/2002 | EP1171608A2 Recombinant and mutant marek's disease virus |
| 01/16/2002 | EP1171607A1 Streptokinase fragments and their use for inhibiting cell death |
| 01/16/2002 | EP1171606A2 Nucleic acid vaccines against rickettsial diseases and methods of use |
| 01/16/2002 | EP1171604A2 Dna sequence and recombinant production of a graminae allergen |
| 01/16/2002 | EP1171601A2 Nucleic acids encoding a mutt domain-containing polypeptide |
| 01/16/2002 | EP1171600A2 Zalpha13: a human secreted protein |
| 01/16/2002 | EP1171597A2 Prostate-restricted gene 30p3c8 expressed in prostate cancer |
| 01/16/2002 | EP1171596A1 Synthetic transmembrane components |
| 01/16/2002 | EP1171595A1 13 transmembrane protein expressed in prostate cancer |
| 01/16/2002 | EP1171590A1 50 human secreted proteins |
| 01/16/2002 | EP1171589A1 A novel family of beta sub-unit proteins from a voltage-gated sodium channel, nucleic acids encoding them and therapeutic or diagnostic uses thereof |
| 01/16/2002 | EP1171588A1 P element derived vector and methods for its use |
| 01/16/2002 | EP1171587A1 Peptide from antigen muc-1 for triggering an immune response to tumor cells |
| 01/16/2002 | EP1171586A2 Methods and compositions for inhibiting the function of polynucleotide sequences |
| 01/16/2002 | EP1171585A1 49 human secreted proteins |
| 01/16/2002 | EP1171579A1 Human tumor necrosis factor receptor tr9 |
| 01/16/2002 | EP1171573A1 Arpe-19 as a platform cell line for encapsulated cell-based delivery |
| 01/16/2002 | EP1171469A1 ANTI-p53 ANTIBODIES |
| 01/16/2002 | EP1171462A2 49 human secreted proteins |
| 01/16/2002 | EP1171460A1 48 human secreted proteins |
| 01/16/2002 | EP1171458A1 50 human secreted proteins |
| 01/16/2002 | EP1171457A1 46 human secreted proteins |
| 01/16/2002 | EP1171456A1 50 human secreted proteins |
| 01/16/2002 | EP1171165A1 Intramyocardial injection of autologous bone marrow |
| 01/16/2002 | EP1171155A2 Therapeutic compositions and methods for enhancing angiogenesis |
| 01/16/2002 | EP1171151A1 Thrombospondin-2 and uses thereof |
| 01/16/2002 | EP1171118A2 Methods and compositions for enhancing delivery of therapeutic agents to tissues |
| 01/16/2002 | EP1171078A2 Compositions and methods for effecting the levels of high density lipoprotein (hdl) cholesterol and apolipoprotein ai, very low density lipoprotein (vldl) cholesterol and low density lipoprotein (ldl) cholesterol |
| 01/16/2002 | EP1170993A1 Non-human transgenic animal whose germ cells and somatic cells contain a knockout mutation in dna encoding 4e-bp1 |
| 01/16/2002 | EP1170992A1 PURIFIED AND ISOLATED $i(piwi) FAMILY GENES AND GENE PRODUCTS AND METHODS EMPLOYING SAME |
| 01/16/2002 | EP0840791B1 Generation of immune responses to prostate-specific antigen (psa) |
| 01/16/2002 | EP0817859B1 Recombinant dna vectors for gene therapy |
| 01/16/2002 | EP0811071B1 Amplifier sequences derived from the desmin gene, vectors comprising same and uses thereof for producing proteins |
| 01/16/2002 | EP0672180B1 Oligonucleotide modulation of protein kinase c |
| 01/16/2002 | CN1331748A Method of recombination and agents useful for same |
| 01/16/2002 | CN1331699A Methods of identifying antigen gene sequences |
| 01/16/2002 | CN1331558A Orally immunogenic bacterial enterotoxins expressed in transgenic plants |
| 01/16/2002 | CN1331330A Polypeptide-human protein phosphatase 12.43 and polynucleotide for coding it |
| 01/16/2002 | CN1331236A Polypeptide-human myoglobulin heavy chain B22.22 and polynucleotide for coding it |
| 01/16/2002 | CN1331187A Polypeptide-human zinc finger protein 8.8 and polynudeotide for coding it |
| 01/16/2002 | CN1077919C Recombinant DNA viral vector for transfecting animal cells |
| 01/15/2002 | US6339149 Isolated nucleic acid molecules which encode tumor rejection antigens found in dage |
| 01/15/2002 | US6339139 Receptor-mediated gene transfer system for targeting tumor gene therapy |
| 01/15/2002 | US6339071 For preventing proliferation of tumor cells |
| 01/15/2002 | US6339070 Gene directed enzyme prodrug therapy (gdept) using in situ antibody generation to provide enhanced selectivity, in cancer therapy; for delivering cytotoxic drugs |
| 01/15/2002 | US6339069 Administering formulation comprising pharmaceutically acceptable carrier; and, liposome comprising a bioactive agent and a lipid component, the lipid component comprising a peptide-lipid conjugate |
| 01/15/2002 | US6339068 Vectors and methods for immunization or therapeutic protocols |
| 01/15/2002 | US6339067 Covalently forming a polymer, from monomers, in presence of a polyion, wherein the polymer is formed outside of any cell, resulting in polymer--polyion complex for delivery to a cell, wherein polyion is not removed from complex |
| 01/15/2002 | US6339066 Antisense oligonucleotides which have phosphorothioate linkages of high chiral purity and which modulate βI, βII, γ, δ, Ε, ζ and η isoforms of human protein kinase C |
| 01/15/2002 | US6339065 Episomal expression vector for human gene therapy |
| 01/15/2002 | US6338962 Therapeutic treatment of genetic disorders by expressing exogenous genes in mammalian cells; introducing non-mammalian dna virus to produce an infected cell; maintain and express the exogenous gene linked to a mammalian active promoter |
| 01/15/2002 | US6338953 Expression of an exogenous gene in a mammalian cell by use of a non-mammalian DNA virus having an altered coat protein |
| 01/15/2002 | US6338951 An isolated protein; diagnosis and therapy for vitamin deficiency, osteoporosis, urogenital disorders and parathyroidism |
| 01/15/2002 | US6338950 DNA encoding LST-1 protein and process for recombinant production of LST-1 protein |
| 01/15/2002 | US6338859 Polymeric micelle compositions |
| 01/15/2002 | US6338851 Method of suppressing an immune response to a transplanted organ or tissue by administering an OX-2 protein |
| 01/10/2002 | WO2002002804A1 Gene expression in biological conditions |